Applied Immunotherapeutics Inc., of Morris, Conn., and The Feinstein Institute for Medical Research at Northwell Health inked a deal in which Applied licensed discoveries in treating inflammation, as well as specific antibodies and drug candidates. Included in the agreement are patent rights covering the use of antibody and small-molecule therapeutics against HMGB1, an established target in inflammatory and autoimmune diseases. Terms were not disclosed.